NYSE

NOVO NORDISK A/S (NVO)

Company Overview

Bagsv'rd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market. The company is also a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity.Novo Nordisk operates through two segments: Diabetes and obesity care and Biopharmaceuticals. While the Diabetes and obesity care segment covers insulins, glucagon-like peptide 1 (GLP-1), other protein-related products, obesity and oral anti-diabetic drugs, the Biopharmaceuticals segment includes hemophilia, growth hormone therapy and hormone replacement therapy.Novo Nordisk's most well-known drugs include Levemir, NovoRapid, Victoza, Ozempic, NovoMix, NovoSeven, NovoThirteen, Ryzodeg, Xultophy, Saxenda, Rybelsus, Esperoct, Sogroya and Norditropin, among several others. The company launched its first product for weight management, Saxenda, in the United States in 2015.In August 2018, Novo Nordisk announced that it has acquired all of the shares of Ziylo Ltd.

Contact Details

Address
Novo Alle 1
City
Bagsvaerd
State
G7
Country
DNK
Zip Code
2880
Phone Number
45-4444-8888
Website
-

Financial Highlights

Day Range

The price range a stock has traded at during the most recent trading period.

-
-
5 Day Range

The price range a stock has traded at during the previous 5 days.

-
-
3 Month Range

The price range a stock has traded at during the previous 3 months.

-
-
52 Week Range

The price range a stock has traded at during the previous 52 weeks.

-
-
Previous Close

The closing price of a stock from the previous day.

-
Open

The price of the stock at the start of today’s market opening.

-
Bid

The amount of money a trader is willing to pay per share for a given stock. 

x
-
Ask

The amount of money a seller wants per share of a given stock.

x
-
Volume

The number of shares traded in a given period. This number illustrates the active interest in the stock at any time.

-
Avg. Volume

The average number of shares traded in a given day.

-
Dividend Yield

A company's annual dividend expressed as a percentage of its current stock price.

-
Recent Dividend

The value a shareholder receives from a company they are invested in for holding their shares.

-
Beta

A measurement of the stock’s volatility in comparison to the market as a whole.

-

Shareholding

Shares Outstanding

Number of shares currently held by investors, including restricted shares owned by the company's officers and insiders.

-
Insider Shareholders

The percentage of shares owned by any officer or board director of the company, including their related or affiliated individuals, families, entities and trusts.

-
Institutional Shareholders

The percentage of shares owned by an institution such as a mutual fund, bank or insurance company.

-
Market Cap

The market value of a company’s outstanding shares. It is used as a measurement tool to determine how large a company is.

-
Revenue TTM

The amount of money a company has made for the trailing twelve-month period.

-
Net Income TTM

A measurement of how much profit they are retaining for the trailing twelve-month period.

-
P/E Ratio

The Price to Earnings (P/E) ratio, is calculated by dividing the stock's most recent share price by the sum of the diluted earnings per share.

-
EPS TTM

Earnings Per Share (EPS) TTM is a company's profit for the trailing twelve-month period divided by its number of common outstanding shares.

-
1 Year Return

A measurement of how much the stock has increased or decreased in the last year.

-

There is no stock data currently available for this time period, please select another option.

Please wait, gathering market data...

Latest Analysis

View More
Latest Analysis |

Investing in Innovation from Fast Company's 2024 List

View More
Investing Data Story Fast Company's Most Innovative Companies 2024.
Latest Analysis |

Inside the Market Dominance of the Top 10 Pharma Giants

View More
Investing Data Story - Big Pharma's Top 10 Outvalue the Next 750 Stocks.
Latest Analysis |

Rising GLP-1 Medication Use to Drive Employer Healthcare Costs

View More
Landscape of money and insurance premiums.
Latest Analysis |

Novo Nordisk Stock Drops on Profit Forecast Revision

View More
NVO stock NOVO Nordisk Logo on handset against stock chart.
Latest Analysis |

Viking Therapeutics Accelerates Weight Loss Drug Development

View More
semaglutide weight loss injection pens prescription or otc medicine concept.
Latest Analysis |

Sign-Ups For Novo Nordisk's Weight Loss Drug Soar In US

View More
problem of being overweight, a person's legs in close-up.